Developing Insulin-like growth factor binding protein 2 (IGFBP2) peptide fragment-based therapeutics to treat functional and behavioral deficits in Ph

Project: Research project

Project Details

Description

Our long-term goal is to develop an effective pharmacological treatment for a subset of ASD patients. Determining feasibility in this study will prepare the company for further pre-clinical work and clinical testing in a Phase II STTR.
StatusFinished
Effective start/end date11/18/19 → 8/31/21

Funding

  • AlisBio LLC (Agmt 7/28/21 // 1R41MH121140-01)
  • National Institute of Mental Health (Agmt 7/28/21 // 1R41MH121140-01)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint